Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Pathology

• Publication date

  1991-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1750499PMCID PMC1886459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient

  2004cited by this paper
• Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis

  2004cited by this paper
• Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

  1991cited by this paper
• Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver.

  1990cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Regulation of TGFβ gene expression in rat liver intoxicated with carbon tetrachloride

  1990cited by this paper
• Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver.

  1990cited by this paper
• Stimulation of hepatic lipocyte collagen production by Kupffer cell‐derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis

  1990cited by this paper
• Ito‐cell gene expression and collagen regulation

  1990cited by this paper
• Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis.

  1990cited by this paper
• Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2.

  1990cited by this paper
• Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis.

  1990cited by this paper
• Expression of transforming growth factor beta 2 during the differentiation of murine embryonal carcinoma and embryonic stem cells.

  1990cited by this paper
• TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence.

  1990cited by this paper
• Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis?

  1990cited by this paper
• Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha.

  1990cited by this paper
• Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice

  1989cited by this paper
• TGF beta gene transcription in normal and neoplastic liver growth.

  1989cited by this paper
• Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments

  1989cited by this paper
• Regulation of liver growth: protooncogenes and transforming growth factors.

  1989cited by this paper
• Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells.

  1989cited by this paper
• In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in nonparenchymal liver cells

  1989cited by this paper
• Cellular localization of laminin gene transcripts in normal and fibrotic human liver.

  1989cited by this paper
• A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

  1988cited by this paper
• Transforming growth factor β responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture

  1988cited by this paper
• Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

  1988cited by this paper
• Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor beta

  1988cited by this paper
• Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family.

  1987cited by this paper
• Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

  1987cited by this paper
• Simultaneous localization of calcitonin mRNA and peptide in a medullary thyroid carcinoma

  1987cited by this paper
• Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.

  1987cited by this paper
• Cell adhesion protein receptors as targets for transforming growth factor-beta action.

  1987cited by this paper
• Type beta transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro.

  1987cited by this paper
• Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.

  1986cited by this paper
• Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture.

  1986cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

  1986cited by this paper
• Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells.

  1986cited by this paper
• Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

  1986cited by this paper
• Transforming growth factor-beta: biological function and chemical structure.

  1986cited by this paper
• Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.

  1985cited by this paper
• Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies.

  1985cited by this paper
• Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat.

  1984cited by this paper
• Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo.

  1983cited by this paper

• Microenvironmental control of the ductular reaction: balancing repair and disease progression

  2025cites this paper
• Current Landscape and Evolving Therapies for Primary Biliary Cholangitis

  2024cites this paper
• Immunology of bile acids regulated receptors.

  2024cites this paper
• Natural Products in Liver Fibrosis Management: A Five-year Review.

  2024cites this paper
• Cholangiokines: undervalued modulators in the hepatic microenvironment

  2023influential citation
• Pathological role of methionine in the initiation and progression of biliary atresia

  2023cites this paper
• Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity

  2023cites this paper
• Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities

  2023cites this paper
• Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis

  2023cites this paper
• A tri-layer decellularized, dehydrated human amniotic membrane scaffold supports the cellular functions of human tenocytes in vitro

  2023cites this paper
• Immunobiology of the biliary tract system

  2022cites this paper
• Understanding the cellular interactome of non-alcoholic fatty liver disease

  2022cites this paper
• A decellularized flowable placental connective tissue matrix supports cellular functions of human tenocytes in vitro

  2022cites this paper
• A Novel Splice Variant of Human TGF-β Type II Receptor Encodes a Soluble Protein and Its Fc-Tagged Version Prevents Liver Fibrosis in vivo

  2021cites this paper
• Sclerosing Sialadenitis Is Associated With Salivary Gland Hypofunction and a Unique Gene Expression Profile in Sjögren’s Syndrome

  2021cites this paper
• Current treatment paradigms and emerging therapies for NAFLD/NASH.

  2021cites this paper
• Extracellular Matrix Remodeling in Chronic Liver Disease

  2021cites this paper
• Orphan nuclear receptor ERRγ regulates hepatic TGF-β2 expression and fibrogenic response in CCl4-induced acute liver injury

  2021cites this paper
• P53 and endoglin, two biomarkers for predicting HBV and hepatocellular carcinoma in Egyptian patients

  2020cites this paper
• Mechanotransduction in Wound Healing and Fibrosis

  2020cites this paper
• Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis

  2020cites this paper
• Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease

  2020cites this paper
• Advances in the clinical use of collagen as biomarker of liver fibrosis

  2020cites this paper
• TGF-β2 silencing to target biliary-derived liver diseases

  2020cites this paper
• A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia

  2020cites this paper
• SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs

  2020cites this paper
• Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?

  2020cites this paper
• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.

  2019cites this paper
• Divergent expression of liver transforming growth factor superfamily cytokines after successful portoenterostomy in biliary atresia☆

  2019cites this paper
• Cholangiocyte pathobiology

  2019cites this paper
• Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans

  2019cites this paper
• Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.

  2019cites this paper
• Native liver fibrosis in biliary atresia : From pathobiology to clinical outcomes

  2019cites this paper
• Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features.

  2018cites this paper
• Extrahepatic Upregulation of Transforming Growth Factor Beta 2 in HCV Genotype 4-Induced Liver Fibrosis

  2018cites this paper
• Insights into the development of peri-biliary fibrosis following hepatic ischaemia-reperfusion injury and the ameliorating effect of PXR activation

  2018influential citation
• Liver fibrosis: Direct antifibrotic agents and targeted therapies.

  2018cites this paper
• LncRNAs: Proverbial Genomic “Junk” or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?

  2018cites this paper
• Determinants of fibrosis progression and regression in NASH.

  2018cites this paper
• 9 – Bile Duct Diseases

  2018cites this paper
• Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells.

  2018cites this paper
• Role of photobiomodulation on the activation of the Smad pathway via TGF-β in wound healing.

  2018cites this paper
• Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies

  2018cites this paper
• TGF-β2 abundance in mice and men:A successful anti-TGF-β2 strategy in biliary-derived liver disease

  2018influential citation
• Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.

  2017cites this paper
• TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases

  2017cites this paper
• Cytokines in the Liver

  2017cites this paper
• Effect of Application of Growth Factors with Dental Implant for Enhancing Bone Formation and Osseo Integration: A Review

  2017cites this paper
• New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets.

  2017cites this paper
• Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis

  2017cites this paper
• TGF-β1 and TGF-β2 abundance in liver diseases of mice and men

  2016cites this paper
• Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.

  2016cites this paper
• Elevated serum &agr;-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story

  2016cites this paper
• The Genetic Basis of Peyronie Disease: A Review.

  2016cites this paper
• Tumor-Suppressive and Tumor-Promoting Role of Tgf-β in Hepatocellular Carcinoma

  2016cites this paper
• Epithelial-mesenchymal transition in liver fibrosis (Review)

  2016cites this paper
• Epithelial-mesenchymal transition in liver fibrosis.

  2016cites this paper
• THROMBOSIS AND HEMOSTASIS Fibrin deposition following bile duct injury limits fi brosis through an a M b 2-dependent mechanism

  2016cites this paper
• The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.

  2016cites this paper
• The expression of epithelial–mesenchymal transition–related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia

  2015cites this paper
• Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts

  2015cites this paper
• Liver fibrosis: Common mechanisms and antifibrotic therapies.

  2015cites this paper
• Hsp90 and hepatobiliary transformation during sea lamprey metamorphosis

  2015cites this paper
• Original Article Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease

  2015cites this paper
• PDGF-Mediated Regulation of Liver Fibrosis

  2015cites this paper
• A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.

  2015cites this paper
• Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.

  2015cites this paper
• Immunomodulatory effects of transforming growth factor-β in the liver.

  2014cites this paper
• The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts

  2014cites this paper
• Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats.

  2014cites this paper
• Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.

  2014cites this paper
• Coming together is a beginning: the making of an intervertebral disc.

  2014cites this paper
• Immunohistochemical study for the origin of ductular reaction in chronic liver disease.

  2014cites this paper
• Toxicogenomic analysis reveals profibrogenic effects of trichloroethylene in autoimmune-mediated cholangitis in mice.

  2014cites this paper
• Anchoring Hepatic Gene Expression with Development of Fibrosis and Neoplasia in a Toxicant-induced Fish Model of Liver Injury

  2013cites this paper
• Biliary Epithelial Senescence and Plasticity in Acute Cellular Rejection

  2013cites this paper
• Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation.

  2013cites this paper
• Immunohistochemical localization of epidermal growth factor receptors in the liver of normal and streptozotocin-induced diabetic rats

  2013cites this paper
• Role of cytokines and chemokines in non-alcoholic fatty liver disease.

  2012cites this paper
• Inhibition of Integrin Alphavbeta 6 on Cholangiocytes Blocks Tgfbeta Activation and Retards Biliary Fibrosis Progression

  2012cites this paper
• Advances in cholangiocyte immunobiology.

  2012cites this paper
• 10 – Diseases of the bile ducts

  2012cites this paper
• 2 – Cellular and Molecular Techniques

  2012cites this paper
• Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice

  2012cites this paper
• Autocrine regulation of biliary pathology by activated cholangiocytes.

  2012influential citation
• Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer

  2011cites this paper
• Biliary Epithelial Cells

  2011cites this paper
• The role of the renin–angiotensin system in liver fibrosis

  2011cites this paper
• Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.

  2011cites this paper
• The use of a recombinant single chain antibody in the investigation of liver fibrosis

  2011cites this paper
• Involvement of c-Ski Oncoprotein in Carcinogenesis of Cholangiocacinoma Induced by Opisthorchis viverrini and N-nitrosodimethylamine

  2011cites this paper
• Endoglin Upregulation in the Liver after Bile Duct Ligation in Rats

  2011cites this paper
• Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?

  2011cites this paper
• Epithelial–Mesenchymal Interactions in Biliary Diseases

  2011cites this paper
• Hepatoprotective role of bis-demethoxy curcumin analog on the expression of matrix metalloproteinase induced by alcohol and polyunsaturated fatty acid in rats

  2010cites this paper
• Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive?

  2010cites this paper
• Mechanisms of Liver Fibrosis

  2010cites this paper
• Portal fibroblasts: Underappreciated mediators of biliary fibrosis

  2010cites this paper
• Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model.

  2010cites this paper
• Involvement of cholangiocyte proliferation in biliary fibrosis.

  2010cites this paper